UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 4, 2010
 
PFIZER INC.
(Exact name of registrant as specified in its charter)

Delaware
1-3619
13-5315170
(State or other
(Commission File
(I.R.S. Employer
jurisdiction of
(Number)
Identification No.)
incorporation)
    
 
235 East 42nd Street
10017
New York, New York
(Zip Code)
(Address of principal executive offices)
 
Registrant's telephone number, including area code:
(212) 733-2323

Not Applicable
(Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
Item 2.02 Results of Operations and Financial Condition

On May 4, 2010, Pfizer Inc. (“Pfizer”) issued a press release announcing its financial results for the first quarter of 2010. The information contained in the press release is deemed to be “filed” under the Securities Exchange Act of 1934 as Exhibit 99 to this report, and such press release is incorporated herein by reference.
 
Item 9.01 Financial Statements and Exhibits

(d)  Exhibits
 
Exhibit 99  -   
 
SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

PFIZER INC.
   
By:
/s/ Matthew Lepore
 
Matthew Lepore
 
Vice President, Chief Counsel - Corporate Governance,
 
and Assistant General Counsel

Dated: May 4, 2010

 
 
 

EXHIBIT INDEX

 
Description
     
99
  
Press Release of Pfizer Inc. dated May 4, 2010, reporting Pfizer's financial results for the first quarter of 2010.